IL100938A0 - Polypeptides and peptides,particularly recombinant polypeptides and peptides,and nucleic acids coding for the same and their use in the diagnosis of tuberculosis - Google Patents

Polypeptides and peptides,particularly recombinant polypeptides and peptides,and nucleic acids coding for the same and their use in the diagnosis of tuberculosis

Info

Publication number
IL100938A0
IL100938A0 IL100938A IL10093892A IL100938A0 IL 100938 A0 IL100938 A0 IL 100938A0 IL 100938 A IL100938 A IL 100938A IL 10093892 A IL10093892 A IL 10093892A IL 100938 A0 IL100938 A0 IL 100938A0
Authority
IL
Israel
Prior art keywords
peptides
polypeptides
nucleic acids
tuberculosis
diagnosis
Prior art date
Application number
IL100938A
Other languages
English (en)
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8208544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL100938(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of IL100938A0 publication Critical patent/IL100938A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL100938A 1991-02-14 1992-02-13 Polypeptides and peptides,particularly recombinant polypeptides and peptides,and nucleic acids coding for the same and their use in the diagnosis of tuberculosis IL100938A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91400388A EP0499003A1 (de) 1991-02-14 1991-02-14 Polypeptide und Peptide, insbesondere rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und Verwendung dieser Polypeptide und Peptide in der Tuberkulosediagnose

Publications (1)

Publication Number Publication Date
IL100938A0 true IL100938A0 (en) 1992-11-15

Family

ID=8208544

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100938A IL100938A0 (en) 1991-02-14 1992-02-13 Polypeptides and peptides,particularly recombinant polypeptides and peptides,and nucleic acids coding for the same and their use in the diagnosis of tuberculosis

Country Status (12)

Country Link
US (2) US5955356A (de)
EP (2) EP0499003A1 (de)
JP (1) JPH06504909A (de)
AT (1) ATE153697T1 (de)
AU (1) AU659822B2 (de)
CA (1) CA2104111C (de)
DE (1) DE69220042T3 (de)
DK (1) DK0571420T4 (de)
ES (1) ES2103928T5 (de)
GR (1) GR3024408T3 (de)
IL (1) IL100938A0 (de)
WO (1) WO1992014823A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
AU1097795A (en) * 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5935568A (en) * 1995-05-18 1999-08-10 National Jewish Medical & Research Center Gene therapy for effector cell regulation
WO1996040236A1 (en) * 1995-06-07 1996-12-19 National Jewish Center For Immunology And Respiratory Medicine Isolated formylated bacterial peptides, nucleic acid molecules and uses thereof
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
GB9714242D0 (en) * 1997-07-07 1997-09-10 Mini Agriculture & Fisheries Glycosylation peptides
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
AU5294000A (en) * 1999-05-28 2000-12-18 Promega Corporation Antibodies specific for mycobacterial polypeptides and uses thereof
GB0006693D0 (en) * 2000-03-20 2000-05-10 Glaxo Group Ltd Vaccine
AU2001271963A1 (en) * 2000-07-10 2002-01-21 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
US20030199012A1 (en) * 2002-02-01 2003-10-23 Ho John L. Compositions and methods for treatment of infectious and inflammatory diseases
US20050267025A1 (en) * 2002-02-01 2005-12-01 Ho John L Compositions and methods for treatment of infectious and inflammatory diseases
MX2007005256A (es) 2004-11-16 2008-03-11 Crucell Holland Bv Vacunas multivalentes que comprenden vectores virales recombinantes.
US20120321656A1 (en) * 2011-06-20 2012-12-20 Matthias Rath Oligopeptides and their use for treating infectious diseases
US20140349320A1 (en) * 2011-12-15 2014-11-27 The Trustees Of The University Of Pennsylvania Using Adaptive Immunity to Detect Drug Resistance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264550A (en) * 1985-04-15 1993-11-23 Scios Nova Inc. Human anti-inflammatory phospholipase inhibitor protein
US4689397A (en) * 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
WO1990010701A1 (en) * 1989-03-08 1990-09-20 Commonwealth Scientific And Industrial Research Organisation Expression system for actinomycetes and related organisms
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes

Also Published As

Publication number Publication date
EP0499003A1 (de) 1992-08-19
DE69220042T3 (de) 2005-12-01
US5955356A (en) 1999-09-21
JPH06504909A (ja) 1994-06-09
ES2103928T5 (es) 2005-09-01
EP0571420B2 (de) 2005-03-16
DE69220042T2 (de) 1997-12-11
ATE153697T1 (de) 1997-06-15
AU659822B2 (en) 1995-06-01
US6638511B1 (en) 2003-10-28
EP0571420A1 (de) 1993-12-01
DK0571420T3 (da) 1997-12-29
EP0571420B1 (de) 1997-05-28
GR3024408T3 (en) 1997-11-28
ES2103928T3 (es) 1997-10-01
CA2104111C (en) 2008-01-08
AU1223492A (en) 1992-09-15
DK0571420T4 (da) 2005-06-20
CA2104111A1 (en) 1992-08-15
DE69220042D1 (de) 1997-07-03
WO1992014823A1 (en) 1992-09-03

Similar Documents

Publication Publication Date Title
IL100938A0 (en) Polypeptides and peptides,particularly recombinant polypeptides and peptides,and nucleic acids coding for the same and their use in the diagnosis of tuberculosis
IL95742A (en) Recombinant polypeptides and peptides nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
EP0776209A4 (de) Polynukleinsäuren und proteine aus einem "porcine reproductive and respiratory syndrome virus" und ihre verwendung
EP0347365A3 (de) HIV-2-Virusvarianten
MD970099A (en) Protein having a cytokin-type activity, recombinant DNA coding for this protein, transformed cells and microorganisms
GR3033328T3 (en) Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis.
CA2121364A1 (en) Vaccines for actinobacillus pleuropneumoniae
EP0811684A3 (de) Oxytocin-Rezeptor Varianten und Teile, dafür kodierende DNS
IL88378A0 (en) Molecular cloning of the human interferon-gamma receptor
EP0919621A4 (de) Menschliche tak1 und für diese kodierende dna
ES2054129T3 (es) Procedimiento para la expresion de un gen recombinante.
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
ATE220103T1 (de) Plasmide aus lactobacillus delbrueckii sp.
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren
IL104086A0 (en) Novel translational activating sequence